PYX Resources: Achieving volume and diversification milestones. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Here's a new interview with the CEO, whose target is to become a �1 billion company - a three-bagger from here: Https://www.compelo.com/tech-firm-ideagen-new-ceo/ Extract: "Industry lags behind in tech for compliance Ideagen operates in a corner of the tech community that is slightly behind the curve traditionally, according to Ben. Many organisations still use spreadsheets or, at even worse, paper filing systems to log issues related to risk and compliance. It means there is plenty more room for growth not just in the UK, but globally. Ben adds: �We want to double the business over the next three years in terms of staff, revenue and value of the company. �That will be a mixture of double-digit organic growth and acquisitions in the UK and US. �If there are opportunities to be more aggressive then we will take them because we want to be worth �1bn in five years.� According to a report by Grand View Research last year, the global governance, risk management and compliance market was worth �16.5bn in 2016 � but this could reach �48bn by 2025. Having already built a strong reputation and client base, Ideagen wants to be a key component of it going forward. �There�s a greater appetite within the business world for the quality, safety and compliance solution we supply,� adds Ben. �There�s more regulatory red tape and if things go wrong, people die or lose money. Businesses take their responsibility around this extremely seriously. �But there�s no market leader there like an IBM � there�s no 800-pound gorilla in the market. �We�re looking to consolidate the marketplace and grow to take charge of it.�
i used to trade this in 2013 about 25p to 30p , looks like long term investment pays not the trading . 25 years of trading still haven't learned.
Strong finish for techs across the pond the Nsdq closing 1.5% up on Friday and near 10% up ytd. This could be the week for Idea to post historic highs (above 130) as the Medforce acquisition beds in. Not sure whether investors have cottoned-on to what an excellent bolt-on purchase that was.
Sage, Mfocus both lower the t350 u/c with Idea gaining 5 on the session (18 deals 144k traded). Doubt we will test historic high today as the background noise on trade worries will dominate mrkt action.
Lovely long-term contract win - I like the comment about this being a potentially 22-year deal..... Https://www.ideagen.com/company/news/ideagen-teams-up-with-connect-plus-for-m25-project/ "Ideagen teams up with Connect Plus for M25 process and safety management project 30 May 2018 Ideagen�s Coruson software becomes the system that underpins safety and quality reporting processes behind the motorway works and operations Connect Plus, one of the major firms involved in the 30-year project to renew, improve, and maintain the M25, has teamed up with UK software firm Ideagen. Ideagen�s Coruson software will be implemented by Connect Plus to enhance processes relating to safety, quality and environmental management. Connect Plus is in the middle of a long-term upgrade and maintenance project to enhance the M25 motorway route. They are involved in supervising contractors as well as providing maintenance work and small improvement schemes. Coruson will become its health, safety, sustainability, environment and quality management system, with around 650 users reporting into the system..... ......Phill added: "This project is all about longevity. We are looking at the potential of a 22-year relationship between ourselves and both Ideagen and Coruson."
Slightly better day for techs, Sage & Mfocus added and Idea tagged along behind 1.5 to the good. No crystal ball but imo 140 is a long way off which potentially would be my exit point ex any game changer for the Co and share price. How much being on Aim is hindering the sp i dont know but for sure many funds are locked out from investing in Aim tiddlers and those with mrkt caps of below £500m however good the nos and you cannot fault Idea in that regard. I guess we'll never know but maybe a 200 stock by now?
Excellent long-term contract entered into with Connect Highway mainteance for the UK Motorway system (see update from Idea home site). Surprised nobody sold on the news as these updates usually prompt sellers. Wouldn't buy on this news as its way too 'fractious' but accumulating this type of contract long-term must be very good news considering the scope for add on's. The market ain't interested in 5 year projects as regrettable are mist pis. A hold is the best I can advise.
Scrappy small lot selling knocked 6 off the sp on a poor day all round for equities. Sage (-17) & Mfocus (-27) as the 350 fell off c.2% and c.21% ytd. Idea is off c.9% this last week and long termers might consider 120 a good top up price. I'm in no rush to add as my timing is invariably bad. I'll wait and see if results day provide us with some good new 'outlook' news.
No-one should be surprised at the falling sp...wait for a better buy entry.
Always good to sell on the news...
I think everyone in Nottingham is selling the stock...for a backwater Aim stock there sure are a hell of a lot of investors!.. (Pub talk)...
Also Shares Mag tipped Idea last wks issue....
Interesting interview about the recent Medforce acquisition in the USA: Http://www.hmenews.com/article/medforce-looks-ideagen-help-it-branch-out Extract: "Medforce is a growing, profitable and cash generative organization that has successfully developed its Center suite of enterprise information management, workflow, and compliance software since 1993. Ideagen has always acquired organizations with strong intellectual property, integrating that IP with our existing product suite. As an example, Medforce�s Center suite of products is used by more than 300 customers globally, supporting business process productivity and legal compliance, and we fully expect to be presented with enhanced cross-sell and integration opportunities going forward, with Medforce�s CommandCenter, ContentCenter and SignCenter of particular interest."
I have seen some '19 forecasts of a very conservative nature. PTP of £10-11m and t/o £35m. Be disappointed if Idea cannot top those nos!
Can't argue with that closing at near days high (132) and a 10 gain on the wk certainly helped by the IC article on Idea. Most likely we will be getting revised upward nos for 18/19 which should keep the momentum going North. Happy to be holding here.
IDEA have been tipped in this week's Shares Magazine, and it's an interesting article. It discloses that management have a 200p share price target and notes that current forecasts could be beaten "by a wide margin". Other useful snippets: GRC "is a $7bn-a-year GRC market yet it remains highly fragmented. Ideagen, which has been around since 1993, wants to act as an industry consolidator as well as driving consistent organic growth." "It aims to double revenue and profit every three years and has met or beaten those targets in the past. For example, in 2015 it reported revenue of �14.4m and �3.6m pre-tax profit. The year to 30 April 2018 is expected to show �36.1m of sales and �9.7m of pre-tax profit. Throughout this growth the company has remained highly cash generative and paid modest dividends. The US is now its number one growth market, as it is the world�s single biggest place for GRC spending. That means accelerating acquisitions growth, such as April�s $8.7m purchase of Medforce, a healthcare compliance business." "The net of regulation red tape and compliance accountability is getting ever tighter around industries and organisations across the world. The next big one is EUwide General Data Protection Regulation (GDPR) which comes into force on 25 May and is the latest in a long list of rules designed to keep us better protected. All this puts UK software supplier Ideagen (IDEA:AIM) in a sweet spot thanks to its wide range of off-the-shelf specialised tools. The Midlands-based company concentrates on what it calls the governance, risk and compliance (GRC) space, providing information management solutions to highly regulated industries. Think healthcare, aviation, banking/finance, complex manufacturing, defence and energy."
'Nother nice pick up for Q- Pulse in the Falklands!! Blimey that's the first time I've heard of them since the aggro v Argentina back in the 80's. Every little helps as did some chunky buys late recorded. Mfocus down Sage, t350 & TM100 all up. US all small % losses (Nsdq off 16).
Up 4...don't mean zilch. Im beginning to worry that the Co value is far outstripping shareholders funds value, which is kinda like its supposed to do with a low tier go - go stock. Just saying like....if your twitchy?
Great underlying demand for these shares, and today's news may have contributed to the new highs: Https://www.ideagen.com/company/news/falkland-islands-health-and-social-services-choose-q-pulse/ "Ideagen�s quality management software to be rolled out across Falkland Islands� health and social services 17 May 2018 King Edward VII Memorial Hospital will implement Ideagen�s Q-Pulse software for improved quality control, visibility and efficiency of safety and service levels Ideagen is to work with the Falkland Islands� Health and Social Services Department to help improve local services for residents and visiting tourists. Based in Stanley � the Islands� capital � King Edward VII Memorial Hospital is the only dedicated medical facility within the Falklands. The hospital will be rolling out Ideagen�s Q-Pulse software to centralise documentation and data management, while standardising operational processes. Q-Pulse is used by hundreds of healthcare organisations globally and will provide staff working for the Health and Social Services Department with control, visibility and improved continuity when following practices based closely on healthcare standards, which are currently mandatory in the UK. etc"
All sellers if you believe the lse nos...I dont. Don't pay a lot of attention to daily vols up or down. Focus on what Idea can earn 2--5 years down the line in increasing eps as the Co expands into the US market and beyond. Not sure if this is a "bottom drawer" stock but must be pretty damn near it.
Big jump in lumpy trading vols last wk and yesterday....fairly unusual here but I'm not reading anything into it.
Statement from Mfocus little changed. Debt equates to c.713pps or c.£3.1bn. Mrkt cap £5.5bn.
Techs on the way down with Sage and Mfocus both off despite a bullish start in N.Y. Idea on the right side of the line atm but i sure wouldn't put my last penny in here given that most IG clients are short the ftse. Idea is doing very well atm but when did that ever mean anything? Those of a nervous disposition and in profit should consider watching from the sidelines.
Good session yesterday, 43 deals and c.a million vol, lots of lumpy sells balanced by buyers on the excellent update.... not only the nos but I was cheered by the Co expecting to double revenues and earnings every three years. Contrast that with the poor results from Sage and Mfocus which still head the tables for 'most wanted' among pis. Valued at c.£300m idea is still a minnow in the tech world and needs a step change from here to reach £500m valuation. That's gonna be a lot harder to achieve - the slowly slowly catchee monkey strategy has paid off so far. I doubt that the nos alone will take us up to the Championship.
Nice comment too about doubling revenues and adjusted EBITDA every three years. Techmarketview like the statement and the Board reshuffle. BD came across very well at Mello, and DH should continue to thrive in his new role: Http://www.techmarketview.com/ukhotviews/archive/2018/05/08/ideagen-appoints-new-ceo-to-drive-strategy-objectives "Tuesday 08 May 2018 Ideagen appoints new CEO to drive strategic objectives ideagenA trading update from Ideagen, the AIM-listed specialist in quality, safety, risk, audit and performance management software, shows that firm has grown revenue and adjusted EBITDA for the ninth consecutive year. The company is expecting to report revenue up 33% to c�36m and adjusted EBITDA up 40% to c�11m for the 12 months to the end of April 2018. Organic revenue growth looks set to come in at 11% (Ideagen has been acquisitive, including a purchase made in the US just last month). To sustain the execution of its objective of doubling revenues and adjusted EBITDA every three years, Ideagen is making some adjustments to its leadership structure. Former CEO, David Hornsby, has become Executive Chairman � with a specific remit around strategy, M&A and Investor Relations. Ben Dorks (former Chief Customer Officer) will take Hornsby�s position as CEO � focusing in particular on operational performance, customer acquisition and retention, and product development. Both seem like sensible moves to us, with the Execs playing to their strengths."